Adduction of soluble proteins with malondialdehyde-acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation

Alcoholism: Clinical and Experimental Research

Volumn 26, Issue 1, 2002, Pages 94-106

  Willis, Monte S ^a,c   Klassen, Lynell W ^a,b   Tuma, Dean J ^a,b   Sorrell, Michael F ^a,b   Thiele, Geoffrey M ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b VA Alcohol Research Center   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adducts; Aldehydes; Autoimmunity; Immune Responses; Scavenger Receptors

Indexed keywords

ACETALDEHYDE; IMMUNOGLOBULIN G1; LYSOZYME; MALONALDEHYDE; PROTEIN; SCAVENGER RECEPTOR;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALIA;

EID: 0036148631     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2002.tb02436.x     Document Type: Article

References (56)

1. Disruption of T-cell tolerance by directing a self antigen to macrophage-specific scavenger receptors
2. Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages
3. Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope
4. Processing and presentation of hen egg-white lysozyme by macrophages
5. Differential requirements for antigen processing by macrophages for lysozyme-specific T-cell hybridomas
6. Enzymic and immunochemical properties of lysozyme. I. Derivatives modified at tyrosine. Influence of nature of modification on activity
7. Endocytosis of formaldehyde-treated serum albumin via scavenger pathway in liver endothelial cells
8. Crystal structure of the complex of the variable domain of antibody D1.3 and turkey egg white lysozyme: A novel conformational change in antibody CDR-L3 selects for antigen
9. Cell-mediated immunity in alcoholic liver disease. Veterans Administration Cooperative Study #275
10. Cell-mediated hepatic injury in alcoholic liver disease
11. Thymocyte injury after in vitro chemical exposure: Potential mechanisms for thymic atrophy
12. Alcohol abuse, alcoholism, and damage to the immune system - A review
13. Iodination of the normal and buried tyrosyl residues of lysozyme. I. Chromatographic analysis
14. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid
15. Pathology of alcoholic liver disease
16. Immunity to tetanus: Tetanus antitoxin and anti-BIIb in human sera
17. Spectrophotometric determination of microgram quantities of protein without nucleic acid interference
18. Method for quantitation of IgG subclass antibodies in mouse serum by enzyme-linked immunosorbent assay
19. Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages
20. Specificity of receptor-mediated recognition of malondialdehyde- modified low density lipoproteins
21. IgG subclass distribution of antibodies against S. aureus teichoic acid and alpha-toxin in normal and immunodeficient donors
22. Subclass distribution of human anti-Staphylococcus aureus alpha toxin antibodies: Suggestion of an IgG1, IgA1, IgG4 switch pattern
23. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: Detection of 4-hydroxynonenal-and malondialdehyde-protein adducts
24. The position of the active tryptophan residue in lysozyme
25. Iodination of lysozyme. II. Reactivity and position of tyrosine residues
26. Iodination of lysozyme. I. Differential iodination of tyrosine residues
27. Scavenger receptor for aldehyde-modified proteins
28. Oxidation of lysozyme by iodine: Isolation of an inactive product and its conversion to an oxindolealanine-lysozyme
29. Observation of a new nonfluorescent malondialdehyde-acetaldehyde- protein adduct by 13C NMR spectroscopy
30. Studies on peroxidized lipids. V. Formation and characterization of 1,3-dihydropyridine-3,5-dicarbaledhydes as model of fluorescent components in lipofusion
31. Immune mechanisms of alcohol-induced liver disease
32. Amino terminus of apolipoprotein B suffices to produce recognition of malondialdehyde-modified low density lipoprotein by the scavenger receptor of human monocyte-macrophages
33. Spectrophotometric titration of tyrosine residues in human lysozyme
34. Enzyme-linked immunosorbent assay determination of specific rubella antibody levels in micrograms of immunoglobulin G per milliliter of serum in clinical samples
35. Quantitation of antibody isotypes in solid-phase assays. Comparison of myeloma protein and monoisotypic antibody standards
36. Maleylated-BSA induces hydrolysis of PIP2, fluxes of Ca2+, NF-kappaB binding, and transcription of the TNF-alpha gene in murine macrophages
37. Cytotoxic and chemotactic potencies of several aldehydic components of oxidised low density lipoprotein for human monocyte-macrophages
38. Scavenger receptor for malondialdehyde-modified high density lipoprotein on rat sinusoidal liver cells
39. Mechanism of virus-induced Ig subclass shifts
40. The macrophage scavenger receptor type A directs modified proteins to antigen presentation
41. Scavenger receptors in innate immunity
42. Scavenger receptors: Diverse activities and promiscuous binding of polyanionic ligands
43. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease
44. The metabolism of native and malondialdehyde-altered low density lipoproteins by human monocyte-macrophages
45. Modulation of T-cell cytokine profiles and peptide-MHC complex availability in vivo by delivery to scavenger receptors via antigen maleylation
46. Endocytic uptake of nonenzymatically glycosylated proteins is mediated by a scavenger receptor for aldehyde-modified proteins
47. The generation of cytotoxic T lymphocytes against acetaldehyde-modified syngeneic cells
48. Long-term ethanol administration alters the degradation of acetaldehyde adducts by liver endothelial cells
49. Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant
50. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration
51. Cathepsin D, but not cathepsin B, releases T-cell stimulatory fragments from lysozyme that are functional in the context of multiple murine class II MHC molecules
52. + T cells from mice transgenic for an alphabet TCR
53. Iodination of the normal and buried tyrosyl residues of lysozyme. II. Spectrophotometric analysis
54. Detection of circulating antibodies to malondialdehyde-acetaldehyde adducts in ethanol-fed rats
55. Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme-linked immunosorbent assay
56. Mechanisms of acetaldehyde-mediated growth inhibition: Delayed cell cycle progression and induction of apoptosis